eScreen, based in Overland Park, KS, deploys a well-regarded automated platform and FDA-authorized reader for the gathering, handling and reporting of non-regulated and regulated urine drug screens.

Global private equity firm The Carlyle Group today announced it has made an investment in eScreen, Inc., a leading provider of instrumented drug screening and electronic hiring program management ...

Alere eScreen is expanding in Kansas City, MO with a $6.8 million investment and 30 new jobs. eScreen, Inc., a subsidiary of Alere Inc., is moving its headquarters to Kansas City, MO. In addition to ...

Publicly traded Alere Inc. is paying up to $340 million to buy eScreen Inc., a technology company that specializes in toxicology screening and employee health products and services. The purchase price ...

The headquarters of Alere eScreen will move in October to this building at 8140 Ward Parkway in Kansas City. Kessinger/Hunter A technology company that provides employment screening applications for ...

Medical diagnostics company Alere has entered into an agreement to buy eScreen, Inc., a technology firm that specializes in toxicology screening and employee health products and services, for up to ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. General Manager Chris Tarpey details eScreen’s growth and ...

Health-care products company Alere Inc. said it will acquire eScreen Inc. for $270 million in a deal that will expand the company's presence in the global toxicology market. EScreen specializes in ...

Alere ( ALR), a medical products company focused on integrating rapid diagnostics with health management, recently reported its binding agreement to buy eScreen for a base consideration of $270 ...